223 related articles for article (PubMed ID: 21447665)
1. Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study.
Sun JK; Keenan HA; Cavallerano JD; Asztalos BF; Schaefer EJ; Sell DR; Strauch CM; Monnier VM; Doria A; Aiello LP; King GL
Diabetes Care; 2011 Apr; 34(4):968-74. PubMed ID: 21447665
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.
Miura J; Yamagishi Si; Uchigata Y; Takeuchi M; Yamamoto H; Makita Z; Iwamoto Y
J Diabetes Complications; 2003; 17(1):16-21. PubMed ID: 12505751
[TBL] [Abstract][Full Text] [Related]
3. Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
Sternberg M; M'bemba J; Urios P; Borsos AM; Selam JL; Peyroux J; Slama G
Clin Biochem; 2016 Feb; 49(3):225-31. PubMed ID: 26506116
[TBL] [Abstract][Full Text] [Related]
4. Differential Association of Microvascular Attributions With Cardiovascular Disease in Patients With Long Duration of Type 1 Diabetes.
Gordin D; Harjutsalo V; Tinsley L; Fickweiler W; Sun JK; Forsblom C; Amenta PS; Pober D; D'Eon S; Khatri M; Stillman IE; Groop PH; Keenan HA; King GL
Diabetes Care; 2018 Apr; 41(4):815-822. PubMed ID: 29386250
[TBL] [Abstract][Full Text] [Related]
5. Characterization of circulating and endothelial progenitor cells in patients with extreme-duration type 1 diabetes.
Hernandez SL; Gong JH; Chen L; Wu IH; Sun JK; Keenan HA; King GL
Diabetes Care; 2014 Aug; 37(8):2193-201. PubMed ID: 24780357
[TBL] [Abstract][Full Text] [Related]
6. Pentosidine - a new biochemical marker in diabetic retinopathy.
Salman AG; Mansour DE; Swelem AH; Al-Zawahary WM; Radwan AA
Ophthalmic Res; 2009; 42(2):96-8. PubMed ID: 19546600
[TBL] [Abstract][Full Text] [Related]
7. Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients.
Kerkeni M; Saïdi A; Bouzidi H; Letaief A; Ben Yahia S; Hammami M
Diab Vasc Dis Res; 2013 May; 10(3):239-45. PubMed ID: 23091285
[TBL] [Abstract][Full Text] [Related]
8. Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
Hirata K; Kubo K
Endocr J; 2004 Dec; 51(6):537-44. PubMed ID: 15644571
[TBL] [Abstract][Full Text] [Related]
9. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes.
Genuth S; Sun W; Cleary P; Sell DR; Dahms W; Malone J; Sivitz W; Monnier VM;
Diabetes; 2005 Nov; 54(11):3103-11. PubMed ID: 16249432
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of pentosidine in diabetic patients: an advanced glycation end product.
Sugiyama S; Miyata T; Ueda Y; Tanaka H; Maeda K; Kawashima S; Van Ypersele de Strihou C; Kurokawa K
J Am Soc Nephrol; 1998 Sep; 9(9):1681-8. PubMed ID: 9727377
[TBL] [Abstract][Full Text] [Related]
11. Comment on: Sun et al. Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the Joslin 50-Year Medalist Study. Diabetes Care 2011;34:968-974.
Conway BN; Maynard JD; Orchard TJ
Diabetes Care; 2011 Sep; 34(9):e148; author reply e149. PubMed ID: 21868772
[No Abstract] [Full Text] [Related]
12. Elevated serum levels of AGEs, sRAGE, and pentosidine in Tunisian patients with severity of diabetic retinopathy.
Kerkeni M; Saïdi A; Bouzidi H; Ben Yahya S; Hammami M
Microvasc Res; 2012 Nov; 84(3):378-83. PubMed ID: 22835520
[TBL] [Abstract][Full Text] [Related]
13. Increased concentration of pentosidine, an advanced glycation end product, and interleukin-6 in the vitreous of patients with proliferative diabetic retinopathy.
Nakamura N; Hasegawa G; Obayashi H; Yamazaki M; Ogata M; Nakano K; Yoshikawa T; Watanabe A; Kinoshita S; Fujinami A; Ohta M; Imamura Y; Ikeda T
Diabetes Res Clin Pract; 2003 Aug; 61(2):93-101. PubMed ID: 12951277
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of microvascular complications in adults with type 1 diabetes and newly diagnosed celiac disease.
Leeds JS; Hopper AD; Hadjivassiliou M; Tesfaye S; Sanders DS
Diabetes Care; 2011 Oct; 34(10):2158-63. PubMed ID: 21911773
[TBL] [Abstract][Full Text] [Related]
15. Associations and interactions between lipid profiles, retinopathy and nephropathy in patients with type 1 diabetes: the FinnDiane Study.
Tolonen N; Hietala K; Forsblom C; Harjutsalo V; Mäkinen VP; Kytö J; Summanen PA; Thorn LM; Wadén J; Gordin D; Taskinen MR; Groop PH;
J Intern Med; 2013 Nov; 274(5):469-79. PubMed ID: 23844944
[TBL] [Abstract][Full Text] [Related]
16. [Is the serum concentration of pentosidine a predictor of cardiovascular events in patients with type 2 diabetes and kidney disease?].
Busch M; Franke S; Stein G; Wolf G;
Dtsch Med Wochenschr; 2007 Sep; 132(36):1810-4. PubMed ID: 17726651
[TBL] [Abstract][Full Text] [Related]
17. Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus.
Choudhuri S; Dutta D; Sen A; Chowdhury IH; Mitra B; Mondal LK; Saha A; Bhadhuri G; Bhattacharya B
Mol Vis; 2013; 19():100-13. PubMed ID: 23378723
[TBL] [Abstract][Full Text] [Related]
18. Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA.
Galler A; Müller G; Schinzel R; Kratzsch J; Kiess W; Münch G
Diabetes Care; 2003 Sep; 26(9):2609-15. PubMed ID: 12941727
[TBL] [Abstract][Full Text] [Related]
19. Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM.
Sell DR; Lapolla A; Odetti P; Fogarty J; Monnier VM
Diabetes; 1992 Oct; 41(10):1286-92. PubMed ID: 1397702
[TBL] [Abstract][Full Text] [Related]
20. Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.
Beisswenger PJ; Moore LL; Brinck-Johnsen T; Curphey TJ
J Clin Invest; 1993 Jul; 92(1):212-7. PubMed ID: 8325987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
